This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (47)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Viral Infections  • Pulmonary Diseases  • Pulmonary Diseases, Other  • Genetics  • Genetic Counseling/ Testing/ Therapy  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: A novel coronavirus has been identified as the etiologic agent of severe acute respiratory syndrome (SARS),^1-3 for which there is no specific treatment. Small interfering RNAs (siRNAs) are double-stranded RNAs that direct sequence-specific degradation of messenger RNA in mammalian cells.⁴ It is also possible, however, that siRNAs could specifically interfere with viral RNA.

Methods

We designed six 21-mer SARSis (siRNAs [GENSET SA Ltd, Paris, France] targeting different sites of the replicase 1A region of the SARS coronavirus [SARS-CoV] genome; siRNA sequences in the senses strands: GUGAACUCACUCGUGAGCUCdTdT [SARSi-1]; GUACCCUCUUGAUUGCAUCdTdT [SARSi-2]; GAGUCGAAGAGAGGUGUCUdTdT [SARSi-3]; GCACUUGUCUACCUUGAUGdTdT [SARSi-4]; CCUCCAGAUGAGGAAGAAGdTdT [SARSi-5]; and GGUGUUUCCAUUCCAUGUGdTdT [SARSi-6]). We then performed 3 in vitro experiments to test their antiviral effects. In the first, we transfected monkey kidney cells (FRhk-4) with 1 of the 6 siRNAs. In addition to these 6 groups of cells, we also created 2 groups of control cells—1 transfected with an unrelated siRNA targeting luciferase . . . [Full Text of this Article]

Ming-Liang He, PhD; Bojian Zheng, MD, PhD; Ying Peng, MD, PhD; Joseph S. M. Peiris, PhD; Leo L. M. Poon, PhD; Kwok Y. Yuen, MD, PhD; Marie C. M. Lin, PhD; Hsiang-fu Kung, PhD; Yi Guan, PhD
University of Hong Kong
Hong Kong, China

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rhesus Theta-Defensin Prevents Death in a Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Pulmonary Disease
Wohlford-Lenane et al.
J. Virol. 2009;83:11385-11390.
ABSTRACT | FULL TEXT  

Glucose-regulated Protein 78 Is an Intracellular Antiviral Factor against Hepatitis B Virus
Ma et al.
Mol. Cell. Proteomics 2009;8:2582-2594.
ABSTRACT | FULL TEXT  

RNA Interference Targeted to the Conserved Dimerization Initiation Site (DIS) of HIV-1 Restricts Virus Escape Mutation
Sugiyama et al.
J Biochem 2009;146:481-489.
ABSTRACT | FULL TEXT  

RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy
Alvarez et al.
Antimicrob. Agents Chemother. 2009;53:3952-3962.
ABSTRACT | FULL TEXT  

Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging Infection
Cheng et al.
Clin. Microbiol. Rev. 2007;20:660-694.
ABSTRACT | FULL TEXT  

Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release
Lu et al.
Proc. Natl. Acad. Sci. USA 2006;103:12540-12545.
ABSTRACT | FULL TEXT  

The Prospect of Silencing Disease Using RNA Interference
Shankar et al.
JAMA 2005;293:1367-1373.
ABSTRACT | FULL TEXT  

Clinical Issues and Research in Respiratory Failure from Severe Acute Respiratory Syndrome
Levy et al.
Am. J. Respir. Crit. Care Med. 2005;171:518-526.
ABSTRACT | FULL TEXT